Pilot study of Glucose Monitoring to Determine Rates of Hyperglycemia During Chemotherapy for Early Stage Breast Cancer
Glucose Monitoring to Determine Rates of Hyperglycemia During Chemotherapy for Early Stage Breast Cancer
Sponsor: Breast Cancer Research Foundation
Enrolling: Male and Female Patients
IRB Number: AAAS3402
U.S. Govt. ID: NCT04473378
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The purpose of this study is to identify if blood sugar elevations during chemotherapy may be related to the development of side effects from chemotherapy. This study will help us find out if blood sugar goes up during the course of chemotherapy, and if so, for the amount of time the blood sugar is elevated after a chemotherapy treatment. Results of this study may help us figure out the best way to control blood sugar during chemotherapy in the future.
This study is closed
Investigator
Melissa Accordino, MD
Do You Qualify?
Are you age 18 or older? Yes No
Do you have a history of stage I-III breast cancer? Yes No
Are you scheduled to receive adjuvant or neoadjuvant chemotherapy? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162